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Abstract: The type of fixation used in primary total knee replacement (TKR) may influence the risk
of prosthetic joint infection (PJI). We conducted a systematic review and meta-analysis to assess
published evidence linking type of fixation (cemented, uncemented, or hybrid) with the risk of
PJI following primary TKR. Randomised controlled trials (RCTs) and observational cohort studies
comparing fixation methods and reporting PJI incidence following primary TKR were identified
in MEDLINE, Embase, Web of Science, and Cochrane Library up until November 2018. Summary
measures were relative risks (RR) with 95% confidence intervals (CIs). We identified 32 eligible articles
(24 observational studies and 8 RCTs) involving 1,161,292 TKRs. In pooled analysis of observational
studies, uncemented fixation was associated with a decreased overall PJI risk when compared with
cemented fixation at 0.76 (0.64–0.89). Comparing antibiotic-loaded cemented fixation with plain
cement, there was no significant difference in overall PJI risk at 0.95 (0.69–1.31), but PJI risk was
increased in the first 6-month postoperative period to 1.65 (1.12–2.43). Limited data from RCTs showed
no differences in PJI risk among the fixation types. Observational evidence suggests uncemented
fixation may be associated with lower PJI risk in primary TKR when compared with cemented
fixation. In the early postoperative period, antibiotic-loaded cemented fixation may be associated with
increased PJI risk when compared with plain cement. This may either reflect appropriate selection of
higher risk patients for the development of PJI to cemented and antibiotic-loaded cement or may
reflect a lower PJI risk in uncemented TKR due to factors such as shorter operative time.
Keywords: fixation; cemented; uncemented; hybrid; antibiotic-loaded cement; prosthetic joint
infection; total knee replacement; meta-analysis
1. Introduction
Total knee replacement (TKR) is one of the most common elective surgical procedures performed
worldwide. In 2017 alone, 102,777 TKRs were performed in England, Wales, Northern Ireland, and the
Isle of Man, as recorded in the National Joint Registry (NJR) [1]. In a primary TKR, the knee implants
(femoral and tibial components) may be secured to the bone with (cemented) or without (uncemented)
bone cement (i.e., type of fixation). The TKR construct fixation is referred to as cemented if the femoral
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and tibial implants are bonded to the bone using cement; in uncemented fixation, the femoral and
tibial implants use press-fit into the bone for initial stability and then bone ingrowth into coatings on
the structure of the implant without cement; in hybrid fixation, there is a mixture of fixations, with one
of the implants being cemented and one being uncemented.
Although TKR is often a successful intervention for alleviating pain and improving function
in joint disease, such as osteoarthritis [2], some patients experience complications, such as aseptic
loosening, prosthetic joint infection (PJI), chronic pain, instability, malalignment, and wear [1]. PJI is a
rare but dreaded complication of TKR; it affects between 0.4–1.5% of primary TKRs [3]. PJI and its
management has devastating effects on patients [4] and it is associated with significant morbidity [5–7],
as well as with high healthcare costs [8,9]. With increasing life expectancy and number of people who
will be affected by osteoarthritis, there will be a rise in the numbers of TKRs and the number of patients
affected by PJI is also expected to increase in a proportionate manner [10,11]. In England and Wales,
over a thousand revision operations are performed annually due to PJI of the knee [12].
Patient-, surgery-, and health-system-related factors influence the risk of developing PJI following
a knee replacement [13,14]. Whether surgery-related factors such as fixation methods influence the risk
of developing a PJI following total joint replacement has been a controversial issue, as the evidence has
been inconsistent. In a recent review, our group showed that compared with other fixation methods,
uncemented and antibiotic-loaded cemented fixations carry the lowest risk for PJI following total hip
replacement (THR) [15]. Data on whether fixation methods affect PJI rates differentially following TKR
remains uncertain, as the literature is conflicting. In this context, we aimed to evaluate the body of
evidence linking cemented, uncemented, and hybrid fixation methods with the risk of PJI following
primary TKR, using a systematic review and meta-analysis of both observational and randomised
trial evidence. Our specific objectives were: (i) to compare the nature and magnitude of potential
associations of different fixation methods with risk of PJI; and (ii) to assess if the associations varied by
study and individual level characteristics.
2. Experimental Section
2.1. Data sources and Search Strategy
This review was conducted according to PRISMA and MOOSE guidelines [16,17] (Tables S1 and
S2) and was based on a pre-defined protocol, which has been registered in the PROSPERO International
prospective register of systematic reviews (CRD42018114592). We searched MEDLINE, Embase,
and The Cochrane Library for studies comparing two or more of the following fixation types: cemented,
uncemented, and hybrid, and reported PJI outcomes after primary TKR from inception to November
2018. The computer-based searches combined free and MeSH search terms and combinations of
keywords related to the target population (e.g., “total knee replacement”, “total knee arthroplasty”,
“total joint replacement”), the intervention (e.g., “fixation”, “cemented”, “uncemented”, “cementless”,
“hybrid”), and outcome (e.g., “prosthetic joint infection”, “deep infection”, “infection”). The search was
limited to human studies with no restrictions on language. The detailed search strategy is reported in
Table S3. All titles and abstracts of studies retrieved from the databases were initially screened to assess
their suitability for inclusion. Full-text evaluation of articles potentially meeting eligibility criteria was
conducted independently by two authors (S.K.K. and V.W.) for study selection. Any disagreements
regarding eligibility of an article were discussed and consensus was reached with involvement of a
third author (M.R.W) when necessary. Reference lists of eligible articles and relevant review articles
were manually scanned for additional studies not identified by our original search. Citations of key
studies were checked in Web of Science.
2.2. Eligibility Criteria
Studies were eligible if they were comparative observational cohort designs, case-control designs,
or randomised controlled trials (RCTs) that: (i) recruited participants undergoing primary TKR;
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(ii) compared any two or more of the following fixation types: cemented, uncemented, and hybrid
fixation; and (ii) reported PJI outcomes after a period of follow-up following primary TKR. No
restrictions were imposed on the follow-up duration. We excluded the following studies: (i) the
intervention was based on only revision TKR; (ii) studies of only bilateral TKR or studies reporting
paired fixations (e.g., cemented and uncemented TKR in the same patient); (iii) compared fixation
methods of only one component (tibial or femoral) and did not provide information on the fixation
type of the other component; (iv) and those conducted in selected populations (e.g., patients with
diabetes only).
2.3. Data Extraction and Quality Assessment
One reviewer (S.K.K.) initially conducted the data extraction using a standardised data collection
form. A second reviewer (V.W.) independently checked the extracted data with that in the original
articles. Data on the following were extracted: first author’s name, study publication date, country and
geographical location of study, study design, baseline year, mean age, duration of follow-up, sample
size, intervention and control, number of PJI outcomes, risk estimates (relative risks (RRs), hazard
ratios (HRs), or odds ratios (ORs)), and degree of covariate adjustment (univariable or multivariable).
We assessed the methodological quality of observational studies using the Newcastle-Ottawa Scale
(NOS) [18]. This scale is used for assessing the quality of non-randomised studies and uses a star system
that rates the quality of evidence from a score of zero to nine, based on three domains: selection of
participants; comparability of study groups; and ascertainment of outcomes of interest. The Cochrane
Collaboration’s risk of bias tool was used to assess the quality of RCTs [19].
2.4. Data Synthesis and Analysis
The risk ratios, expressed as RRs with 95% confidence intervals (CIs), were used as the summary
measures of association across studies. Since PJI is considered a rare outcome, reported HRs and ORs
were assumed to approximate the same measure of RR following Cornfield’s rare disease outcome
assumption [20]. Fully multivariable adjusted risk estimates were used when reported, otherwise
crude RRs were calculated from studies that reported raw counts for intervention and control arms.
To minimize the effect of heterogeneity, the inverse variance-weighted method was used to pool RRs
using random-effects models. We reported RRs of the associations for the overall duration of follow-up.
Sub-analyses were also conducted for specific post-operative periods (e.g., first 3–6 months of follow-up)
for studies that reported these data. Heterogeneity across studies was assessed using the Cochrane
χ2 statistic and the I2 statistic [21]. We explored sources of heterogeneity and assessed for interactions
on the associations by pre-defined study-level characteristics using stratified analyses and univariable
meta-regression [22]. For pooled analysis involving 10 or more studies, publication bias was assessed by
visually inspecting a funnel plot and applying Egger’s regression symmetry test bias [23]. We also adjusted
for the effect of publication bias by the use of the Duval and Tweedie’s nonparametric trim-and-fill method,
which imputes hypothetical small missing null or negative studies [24]. All statistical analyses were
performed with Stata release 15 (StataCorp, College Station, TX, USA).
3. Results
3.1. Study Identification and Selection
The literature search strategy, manual scanning of reference lists, and citation check of Web of
Science identified 665 potentially relevant articles. After the initial screening of titles and abstracts,
51 articles remained for full text evaluation. Following detailed full text evaluation, 19 articles were
excluded because: (i) the outcome was not relevant (n = 8); (ii) intervention was not relevant (n = 7);
(iii) population was not relevant (n = 2); and (iv) duplicate studies (n = 2). The remaining 32 articles
based on 24 unique observational cohort studies and eight RCTs met the inclusion criteria and were
included in the review (Figure 1; Table 1; Table S4).
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Table 1. Characteristics of studies included in review.
Author,
Year of
Publication
Year of
Study Country
Indication for Total Hip
Replacement
Average
Age
(Years)
Design, Source of
Data
Fixation Types
Compared
Mean/Median
Follow-Up
Duration, Years
No. of
Participants/
Knees
Infection Outcome
Reported (Definition)
No. of
PJIs
Study
Quality
Wilson, 1990 1973–1987 U.S. NR NR Observationalcohort, Hospital
Uncemented,
cemented, hybrid Up to 6.0 years 4171
Deep infection (Purulent
material obtained from
joint and positive
bacterial culture)
67 4
Duffy, 1998 1985–1987 U.S.
Uncemented (OA 76.4%; RA
16.4%; PTA 5.5%; ankylosing
spondylitis 1.8%); Cemented
(OA 82.4%; RA 11.8%; ancient
sepsis 3.9%; osteonecrosis 2.0%)
59.6 Retrospective cohort Uncemented,cemented 10.0 106
Revision for infection
(NR) 1 4
McCaskie,
1998 1987–1990 U.K.
Cemented (OA 84%);
Uncemented (OA 86%) 68.8–70.2 RCT, Hospital
Uncemented,
cemented 5.0 113 Infection (NR) 1 NA
Pecina, 2000 1985–1991 Croatia OA 68.3%; RA 31.7% 61.0 Observationalcohort
Uncemented,
cemented, hybrid 7.3 142
Revision for infection
(NR) 5 5
Eveillard,
2003 1995–1999 France NR NR
Observational
cohort, Hospital
Antibiotic loaded
cement, plain
cement
At least 1 year 167
Infection (Isolation of
organisms from tissue
sample; confirmed by
surgeon)
9 5
Baker, 2007 1987–1997 U.K. OA 91.4%; RA 7.6%; other 1.0% 70.5 RCT Uncemented,cemented 8.7–8.9 396
Revision for infection
(NR) 11 NA
Beaupre,
2007 1996–2000 Canada Non-inflammatory arthritis 100% 63.4 RCT Uncemented, hybrid 5.0 81 Infection (NR) 6 NA
Jamsen, 2009 1997–2004 Finland
Primary OA 87.9%; secondary
OA 2.7%; RA 7.6%; other arthritis
1.0%; other 0.8%
71.0 Retrospective cohort,FAR and FHDR
Uncemented,
cemented, hybrid 3.1 40,135
Revision for infection
(NR) 387 7
Dowsey, 2009 1998–2005 Australia OA 91.8%; RA 7.8%;osteonecrosis 0.2%; trauma 0.2% 72.0
Retrospective cohort,
Institutional
database
Antibiotic loaded
cement, plain
cement
1.0 1214 PJI (CDC criteria) 18 6
Ghandi, 2009 1998–2006 Canada Primary or secondary OA; RA 66.1 Retrospective cohort,Hospital
Antibiotic loaded
cement, plain
cement
1.0 1625 Deep infection(CDC criteria) 43 5
Namba, 2009 2003–2007 U.S. OA 92.4%; other 7.6% 68.0
Retrospective cohort,
community-based
registry
Antibiotic loaded
cement, plain
cement
NR 22,889 Deep infection(CDC criteria) 182 8
Demey, 2011 2004–2005 France OA (96.9%);chondrocalcinosis (3.1%) 72.3 RCT Hybrid, cemented 2.7–2.8 130 Deep infection (NR) 1 NA
Namba, 2013 2001–2009 U.S. OA 96.8%; PTA 1.2%; RA 2.2%;osteonecrosis 0.4%; other 0.9% 67.4
Retrospective cohort,
Registry
Antibiotic loaded
cement, plain
cement
NR 56,216 Deep SSI (CDC criteria) 404 8
Lass, 2013 2003–2007 Austria
Idiopathic arthritis 88.3%; PTA
5.0%; RA 3.3%; avascular
necrosis 0.8%
66.9 Observationalcohort Uncemented, hybrid 5.0 120
Revision for infection
(NR) 1 5
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Table 1. Cont.
Author,
Year of
Publication
Year of
Study Country
Indication for Total Hip
Replacement
Average
Age (Years)
Design, Source of
Data
Fixation Types
Compared
Mean/Median
Follow-Up
Duration, Years
No. of
Participants/
Knees
Infection Outcome
Reported (Definition)
No. of
PJIs
Study
Quality
Pelt, 2013 NR U.S.
Hybrid (OA 95%; RA 2%; PTA
3%; other 0%); Cemented (OA
90%; RA 7%; PTA 2%; other 1%)
59.3–65.9 Observationalcohort Hybrid, cemented 3.2–4.1 304 Revision for sepsis (NR) 5 5
Hinarejos,
2013 2005–2010 Spain NR 75.9 RCT
Antibiotic loaded
cement, plain
cement
3.2 2948 Deep and superficialinfection (CDC criteria) 85 NA
Qadir, 2014 2000–2010 U.S. NR 68.1 Retrospective cohort,Institutional registry
Antibiotic loaded
cement, plain
cement
1.0 2511 Infection (CDC criteria) 17 6
Gutowski,
2014
2000–2002;
2004–2007 U.S. NR 65.8
Retrospective cohort,
Hospital
Antibiotic loaded
cement, plain
cement
Over a 3.0-year
period 7878 PJI (MSIS criteria) 63 5
Bohm, 2014 2003–2008 Canada OA 100% 70.0 Retrospective cohort,CIHI and CJRR
Antibiotic loaded
cement, plain
cement
2.0 36,681 Revision for infection(NR) 36 6
Choy, 2014 2002–2004 Korea OA 100% 67.8 RCT Uncemented, hybrid 9.5 168 SSI (NR) 2 NA
Lizaur-Utrilla,
2014 1999–2007 Spain OA (92.5%); PTA (7.5%) 51.7 RCT Uncemented, hybrid 7.1 93
Deep wound infection
(NR) 1 NA
Petursson,
2015 1999–2012 Norway Primary OA 90%; other 10% 69.0
Observational
cohort, NAR Hybrid, cemented 11.0 24,680
Revision for infection
(NR) 217 7
Wang, 2015 2003–2012 China OA 87.8%; other 12.2% 64.8 Retrospective cohort,Hospital
Antibiotic loaded
cement, plain
cement
1.0 2293 Deep infection (CDCcriteria) 10 6
Fricka, 2015 2010–2012 U.S. NR 58.6–60.2 RCT Uncemented,cemented 2.0 100 PJI (NR) 1 NA
Tayton, 2016 1999–2012 NewZealand
OA 95%; AVN 0.3%; Trauma
1.2%; RA 3.4%; other 0.2% <55 to >75 *
Prospective cohort,
New Zealand Joint
Registry
Antibiotic-loaded
cement, plain
cement
1.0 64,566 Revision for infection(NR) 179 7
Wu, 2016 2009–2013 Taiwan OA, RA, PTA 69.7 Retrospective cohort
Antibiotic-loaded
cement, plain
cement
1.0–5.0 3152 SSI (CDC criteria) 48 6
Prudhon,
2017 2003–2006 France
OA 88.5%; post-traumatic OA
3.0%; RA 4.5%; patellofemoral
OA 4.0%
73.0 Observationalcohort
Uncemented,
cemented 12.1–13.7 200 Infection (NR) 1 5
Sanz-Ruiz,
2017 2009–2012 Spain NR 76.1–76.4 Prospective cohort
Antibiotic-loaded
cement, plain
cement
2.0 (minimum) 1250 Infection (MSIS criteria) 30 4
Vertullo,
2018 1999–2015 Australia OA 100% 69.0
Observational
cohort, Registry Hybrid, cemented 13.0 39,623
Revision for infection
(NR) 215 7
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Table 1. Cont.
Author,
Year of
Publication
Year of
Study Country
Indication for Total Hip
Replacement
Average
Age
(Years)
Design, Source of
Data
Fixation Types
Compared
Mean/Median
Follow-Up
Duration, Years
No. of
Participants/
Knees
Infection Outcome
Reported (Definition)
No. of
PJIs
Study
Quality
Gwam, 2018 2015 U.S. OA 100% 65.8 Retrospective cohort,NIS database
Uncemented,
cemented NR 167,930 SSI (NR) NR 5
Lenguerrand,
2018 2003–2013 U.K. OA (97.3%); other (2.7%) 69.0
Prospective cohort,
Registry
Uncemented,
cemented 4.6 679,010
Revision for infection
(NR) 3227 7
Miller, 2018 2013–2014 U.S. NR 64.4 Institutionaldatabase
Uncemented,
cemented 2.4–5.3 400 Infection (NR) 1 5
Note: *, age range of participants; CDC, Centres for Disease Control Prevention; CIHI, Canadian Institute for Health Information; CJRR, Canadian Joint Replacement Registry; FAR, Finnish
Arthroplasty Register; FHDR, Finnish Hospital Discharge Register; MSIS, Musculoskeletal Infection Society; NA, not applicable; NAR, Norwegian Arthroplasty Register; NIS, National
Inpatient Sample; NR, not reported; OA, osteoarthritis; PJI, prosthetic joint infection; PTA, post-traumatic arthritis; RA, rheumatoid arthritis; RCT, randomised controlled trial; SSI, surgical
site infection.
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3.2. Study Characteristics and Study Quality
Table 1 provides key characteristics of eligible observational cohort studies and RCTs included in
the review. Overall, the 32 studies included 1,161,292 TKRs and 5706 PJI outcomes. The 24 observational
cohort studies included 1,157,263 TKRs and 5598 PJI outcomes. Of the 24 studies, 11 were conducted
in North America (USA and Canada), eight in Europe (Austria, Croatia, Finland, France, Norway,
Spain, and the United Kingdom), three in the Pacific region (Australia and New Zealand), and two
in Asia (China and Taiwan). Observational studies were published between 1990 and 2018. The
population sources from which these studies were based included arthroplasty and community
registries, hospitals, and institutional databases. The mean/median baseline age of participants ranged
from 59 to approximately 76 years. PJI outcomes were reported in a variety of ways and included
revision for infection, deep infection, and surgical site infection (Table 1). Majority of studies, especially
the registry studies, did not provide any detailed information on the diagnoses of PJI. For studies
reporting the diagnoses of infection, the definitions varied but were mostly based on criteria developed
by Centers for Disease Control Prevention (CDC) [25] and the Musculoskeletal Infection Society
(MSIS) [26]. For registry studies, a previously published and related study has indicated that reporting
of infection as the cause of revision in registry studies reflects the surgeon’s opinion based on clinical
information and findings at surgery [27]. The average overall follow-up for PJI outcomes ranged from
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one year to approximately 14 years. Some studies also reported early postoperative follow-up results
within periods of 30 days to 6 months. The NOS methodological quality of included observational
studies ranged from 4–8.
Of the eight RCTs, five were conducted in Europe (France, Spain, and the United Kingdom),
two in North America (Canada and the United States), and one in Asia (Korea). These trials were
published between 1998 and 2015. Altogether, the RCTs comprised 4029 TKRs and 108 PJI outcomes,
with sample sizes ranging from 81 to 2948 TKRs. The average duration of follow-up for PJI outcomes
ranged from 2 to 9.4 years. Using the Cochrane risk of bias tool, all trials demonstrated a high risk of
bias within 1–5 areas of study quality (random sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assessment, and other bias). All trials had a low
risk of bias for incomplete outcome data and selective reporting. Four trials had an unclear risk of bias
in allocation concealment (Figure S1).
3.3. Fixation Types and PJI Risk
Figure 2 reports RRs (95% CIs) for overall PJI, comparing various fixation types for all studies.
In observational studies, compared with cemented fixation, uncemented fixation was associated with
a lower risk of PJI (8 studies, 892,094 TKRs, and 4118 PJIs) RR 0.76 (95% CI: 0.64–0.89) (Figure S2).
There was no significant evidence of heterogeneity between contributing studies (I2 = 14%; 95% CI:
0–57%; p = 0.318). When the largest study, which was based on the NJR [14], was excluded from
the analysis, the pooled RR was 1.45 (95% CI: 0.85–2.48). There was no significant difference in PJI
risk when hybrid fixation was compared with cemented RR 0.98 (95% CI: 0.80–1.21) or uncemented
fixation RR 0.93 (95% CI: 0.13–6.25) (Figure 2; Figure S3). In pooled analysis of 12 observational
studies (200,442 TKRs, and 1039 PJIs), there was no significant difference in overall PJI risk when
antibiotic–loaded cemented fixation was compared with plain cemented fixation RR 0.95 (95% CI:
0.69–1.31) (Figure 2; Figure S4). There was evidence of significant heterogeneity between contributing
studies (I2 = 71%; 95% CI: 47–84%; p < 0.001), which was partly explained by geographical location
(p for meta-regression < 0.001) and population source (joint registries versus other data sources) (p for
meta-regression = 0.035) (Figure 3). Antibiotic-loaded fixation was associated with decreased PJI risk
in Asian populations, with no difference in risk in other geographical locations. In further analysis
limited to PJI outcomes at 6 months of follow-up in studies providing these data (3 studies, [28–30]
74,955 TKRs, 147 PJIs), antibiotic-loaded cemented fixation was associated with an increased risk of PJI
when compared with plain cemented fixation RR 1.65 (95% CI: 1.12–2.43). There was no evidence of
heterogeneity between contributing studies (I2 = 0%; 95% CI: 0–90%; p = 0.561). In pooled analysis
of 4 studies (48,961 TKRs, 177 PJIs) restricted to PJI diagnosed at 24 or more months of follow-up,
there was no significant difference in PJI risk when antibiotic-loaded cemented fixation was compared
with plain cemented fixation RR 0.73 (95% CI: 0.33–1.63).
In RCTs, there was no difference in PJI risk when uncemented fixation was compared with
cemented or hybrid fixation and when hybrid fixation was compared with cemented fixation (Figure 2;
Figure S5). In one trial based on 2948 TKRs and 85 PJIs, [31], there was no difference in PJI risk
when antibiotic-loaded cemented fixation was compared with plain cemented fixation RR 1.22
(95% CI: 0.80–1.86).
3.4. Publication Bias
A funnel plot for the comparison that involved 12 studies (antibiotic-loaded cement vs. plain
cemented fixation) showed visual evidence of publication bias (Figure S6), which was consistent with
Egger’s regression symmetry test (p = 0.038). Using the trim-and-fill method did not impute any
artificial studies into the meta-analysis.
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Figure 3. Comparison of all antibiotic-loaded cemented fixation with plain cemented fixation in primary
total knee replacement and the risk of prosthetic joint infection in observational studies, grouped
according to several study characteristics. Note: CI, confidence interval (bars); PJI, prosthetic joint
infection; RR, relative risk; *, p-value for meta-regression.
4. Discussion
4.1. Key Find ngs
Based on a systematic review and meta-analysis of observational and interventional evidence,
we have evaluated the body of evidence linking cemented, uncemented, and hybrid fixation methods
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with the risk of PJI following primary TKR. Pooled evidence from observational studies suggests that
uncemented fixation is associated with lower overall PJI risk when compared with cemented fixation.
This reduction in risk, however, lost significance when the largest study [14] was excluded. There were
no differences in PJI risk when hybrid fixation was compared with cemented or uncemented fixation.
There was no significant difference in overall PJI risk when antibiotic-loaded cemented fixation was
compared with plain cemented fixation. However, in analysis limited to the first 6 postoperative months
of follow-up, antibiotic-loaded cement was associated with an increased PJI risk when compared
with plain cemented fixation. Subgroup analyses involving the comparison between antibiotic-loaded
cemented and plain cemented fixation showed evidence of effect modification by geographical location
and population source. Antibiotic-loaded cement compared with plain cemented fixations was
associated with decreased PJI risk in Asian populations. However, given the limited number of studies
available for these subgroup analyses, the results need to be interpreted with caution. Finally, limited
data from RCTs showed no differences in PJI risk between fixation types.
4.2. Comparison with Previous Work
To our knowledge, no previous reviews have evaluated the associations of all fixation types with
the risk of PJI following primary TKR; therefore, it is difficult to make a head-to-head comparison in the
context of previously published work beyond the papers included in this analysis. However, a number
of reviews have compared uncemented versus cemented fixations or antibiotic-loaded cemented versus
plain cemented fixations. Two reviews compared cemented fixation with uncemented fixation in terms
of implant survival but did not compare infection outcomes between the fixation methods [32,33]. In a
pooled analysis of five studies, Wang and colleagues showed no difference between cemented and
uncemented fixation with respect to infection [34]. Consistent with our findings, several published
meta-analyses of observational studies and RCTs have also not demonstrated any difference in the
overall incidence of infection between antibiotic-loaded cement and plain cement fixations in primary
TKR [35–37]. However, based on a larger number of studies and more detailed analyses, our review
presents new observational findings which show that uncemented fixations are associated with lower
PJI risk when compared with cemented fixations (albeit on inclusion of the large NJR study [14]) and
the effects of antibiotic-loaded and plain cemented fixations seem to depend on the timing of the
postoperative period following primary TKR, geographical location, and the source of the data. In our
recent review conducted in primary THR patients, we have also shown that uncemented fixations are
associated with lower PJI risk when compared with cemented fixations [15]. Consistent with the data
in THR patients, the evidence from RCTs in knee patients is also limited and inconclusive.
4.3. Possible Explanations for Findings
Compared to uncemented prostheses, cemented prostheses may cause an increased risk of infection
via a number of pathways. Evidence from studies conducted in THR patients suggest the bone necrosis
caused by direct toxicity or generation of heat during the cemented polymerization process [38] may
create conditions conducive for bacterial growth [39,40]; although in TKR, it is unlikely that the cement
mantle thickness reaches the threshold required to lead to osteonecrosis. Compared to uncemented
TKR, cemented TKR has a longer operating room time [41], which may increase the likelihood of
perioperative contamination [42]. One would expect that antibiotic-loaded bone cement should confer a
lower risk of infection compared with plain bone cement, due to the elution of antibiotics from the bone
cement [43]. However, when the overall evidence was considered, antibiotic-loaded cemented fixations
seemed to be associated with increased PJI risk in the early postoperative period but not at longer-term
follow-up. The elution of antibiotics may only achieve effective concentrations against certain bacteria
or for very short postoperative time periods [43]. Emergence of antimicrobial resistance could be
an explanation; in vitro data suggests that prolonged exposure of micro-organisms to subinhibitory
concentrations of antibiotics promotes mutations that confer resistance [44,45]. Evidence from both
animal and human studies show high rates of antibiotic-resistant infections in antibiotic-loaded
J. Clin. Med. 2019, 8, 828 11 of 15
cement [46,47]. Given that our findings are limited to the observational studies included, it could be
that our observations reflect appropriate selection of low risk patients only to receive plain cement
with higher risk patients receiving antibiotic-loaded cement, with this selection occurring on the
basis of factors not included in, or adjusted for, in the studies included. Other possible explanations
include biases in study designs, such as misdiagnosis of PJI and inability to account for important risk
factors, such as age, sex, and comorbidities, including diabetes mellitus, nature of prostheses, surgical
environment, nature of prior surgical procedures, and other patient factors.
4.4. Implications of our Findings
Though prosthesis design and materials are constantly evolving, the ideal fixation method for TKR
is still under considerable debate [41], and this is because of surgical preferences and inconsistencies
in clinical outcomes reported. Cemented fixation in TKR has been regarded as the gold standard
for several decades, given the extensive evidence on its good clinical outcomes. Discouraging initial
results for uncemented TKRs [48,49] led to a decline in use. However, with the development of
new materials and prosthetic designs, the use of uncemented fixation is becoming an attractive
option among surgeons [50]. Emerging evidence suggests that modern uncemented knee prostheses
have comparable survivorship and clinical outcomes to cemented prostheses. In addition, cemented
fixations have drawbacks, which include longer surgical time, possibility of thermal osteonecrosis,
and complex revisions in the event of a failure [51]. Uncemented fixation, commonly used in younger
patients and those with good bone quality, is approximately three times more expensive than cemented
fixation; however, they have many advantages, which include shorter operative time, providing
a biologic interface between bone and implant leading to a durable fixation, preservation of bone
stock, reduced risk of cement-related complications, such as third body wear from retained loose
fragments, ease of revision in the event of a failure [41,51], and in addition, a lower risk of PJI. There
is a changing demography in the TKR population, as the population with osteoarthritis is getting
younger [52]. Given the large projected increases in the numbers of TKRs that will be performed [11],
the incidence of PJI is also expected to rise. It appears cemented fixation may be associated with
an increased risk of PJI when compared to uncemented fixation. If equivalent outcomes in terms
of revision for other indications can be achieved with modern uncemented TKR when compared to
cemented TKR, then it may be reasonable to recommend surgeons to use an expensive uncemented
fixation (especially for patients at high risk of revision), as it gives comparable clinical outcomes
to cemented fixation, has several advantages, and is also associated with lower PJI risk. However,
the current evidence suggests a higher overall rate of revision for uncemented TKR compared to
cemented TKR [1]. The efficacy of antibiotic-loaded cement compared with plain cement in decreasing
infection has been demonstrated in studies of primary THR [15]. Apart from reasons such as the
development of antibiotic resistance, biases of the study designs, and chance findings, it is difficult to
explain the contrasting findings we have demonstrated in the early postoperative period for TKRs.
However, there is a possibility that antibiotic-loaded cement fixation has no effect on the prevention of
PJI after primary TKA. Wang and colleagues, in their combined analysis of 2293 patients and critical
review of seven articles, concluded that antibiotic-loaded bone cement had no effect on PJI prevention
compared with plain cement in primary TKR [53]. The authors recommended that since previous
studies were based on short-term follow-up (12 months), further studies with long-term follow-up
were needed. Even though the evidence base is limited, antibiotic-loaded cement is commonly used for
primary TKR throughout Europe, whereas in the United States it is mostly used for treating revision
for infection in TKR. Recommendations against its use for primary joint surgery in North America are
based on concerns regarding high costs, allergic reactions, toxicity, and antibiotic resistance [29,54–56].
We acknowledge that much of the evidence is based on observational data, which are limited by biases
such as selection bias and reporting, residual confounding, and uncertainty with coding of fixation
types; hence, the results should be interpreted with caution. Definitive RCTs with long-term follow-ups
are warranted to confirm or refute these findings.
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4.5. Study Strengths and Limitations
We have conducted a comprehensive systematic review and meta-analysis that evaluates the
relationships of cemented, uncemented, and hybrid fixation methods with PJI risk following primary
TKR. We employed a comprehensive search strategy across multiple databases, as well as manual
searches of relevant articles, thereby identifying several additional observational and intervention
studies conducted on the topic. We were able to harmonize the data to a consistent comparison to
enable pooling, and this enhanced interpretation of our findings. In addition, we extracted detailed
data that enabled reporting of estimates for specific time periods, exploration of heterogeneity, and
the assessment of effect modification where possible. Finally, a detailed assessment of the quality of
the included studies (including risk of bias) was conducted using established and validated tools.
There were several limitations to the current study, the majority of which were related to the studies
included in the review, and these should be taken into account when interpreting the results. The lack
of reporting or the heterogeneous definition of PJI employed by included studies could have limited
the validity of the findings. In registry studies, it is well known that PJI diagnosis reflects the
clinical judgement of the surgeon and there are issues relating to under-reporting of revision for PJI,
thus yielding potentially lower incidence estimates of PJI [57]. There were a limited number of studies
(<10) for most of the comparisons reported and these precluded assessment of heterogeneity and effect
modification. The large registry study [14] contributed to the beneficial effect seen in uncemented
fixations. Most of the evidence comes from observational study designs, which are unable to directly
prove causation. In addition, the majority of reported risk estimates were confounded as they were
estimated from the raw data. Finally, some of the studies were conducted decades ago and inclusion of
these data do not take into account the evolving nature of prosthetic materials, surgical procedures,
as well as contemporary antibiotic prophylaxis.
5. Conclusions
Aggregate observational evidence suggests uncemented primary TKR may be associated
with lower PJI risk compared with cemented primary TKR. In the early postoperative period,
antibiotic-loaded cemented fixation may be associated with increased PJI risk when compared
with plain cement. There are no differences in PJI risk when hybrid fixations are compared with
cemented or uncemented fixations. Data from RCTs is limited and uncertain.
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